Influence of a uricosuric drug on connective tissue metabolism.
D001565:Benzoates / Q000494:pharmacology; D001572:Benzofurans / Q000494:pharmacology* / Q000627:therapeutic use; D001593:Benzyl Compounds / Q000627:therapeutic use; D001966:Bromine / Q000494:pharmacology; D002356:Cartilage / Q000187:drug effects / Q000378:metabolism*; D002807:Chondroitin / Q000096:biosynthesis; D003404:Creatinine / Q000378:metabolism; D006073:Gout / Q000188:drug therapy* / Q000378:metabolism; D006801:Humans; D007700:Kinetics; D007717:Knee; D010430:Pentosyltransferases / Q000378:metabolism; D011687:Purines / Q000378:metabolism; D013431:Sulfates; D013466:Sulfurtransferases / Q000378:metabolism; D013997:Time Factors; D014527:Uric Acid / Q000378:metabolism
D001565:Benzoates; D001572:Benzofurans; D001593:Benzyl Compounds; D011687:Purines; D013431:Sulfates; D014527:Uric Acid; D002807:Chondroitin; D003404:Creatinine; D010430:Pentosyltransferases; D013466:Sulfurtransferases; D001966:Bromine